XM does not provide services to residents of the United States of America.
B
B

BayerAG

News

Bayer: Receives Breakthrough Therapy Designation In China For Bay 2927088 In High Unmet Need Patients With Her2-Mutant Non-Small Cell Lung Cancer

BRIEF-Bayer: Receives Breakthrough Therapy Designation In China For Bay 2927088 In High Unmet Need Patients With Her2-Mutant Non-Small Cell Lung Cancer June 11 (Reuters) - Bayer AG BAYGn.DE : RECEIVES BREAKTHROUGH THERAPY DESIGNATION IN CHINA FOR BAY 2927088 IN HIGH UNMET NEED PATIENTS WITH HER2-MUTANT NON-SMALL CELL LUNG CANCER Further company cov
B

Asmi, Beiersdorf, SSE

EUROPE RESEARCH ROUNDUP-Asmi, Beiersdorf, SSE June 7 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Asmi, Beiersdorf and SSE, on Friday. HIGHLIGHTS * Arcadis NV ARDS.AS : KBC Securities raises to accumulate from buy * Asmi ASMI.AS : Berenberg raises target price to EUR 720 from EUR 640 * Beiersdorf BEIG.DE : HSBC raises target price to EUR 158 from EUR 152 * Nibe Industrier AB NIBEB.ST : HSBC cuts to hold from buy * SSE SSE.L : HS
A
B
B
C
D
E
E
I
J
L
L
S
W

Asmi, Beiersdorf, SSE

CORRECTED-EUROPE RESEARCH ROUNDUP-Asmi, Beiersdorf, SSE Corrects Greenyard NV entry to say KBC Securities raises target price to EUR 9.5 from EUR 8.5 (not 6.30) and Arcadis NV entry to say KBC Securities cuts (not raises) to 'accumulate' from 'buy'; raises target price to EUR 66 from EUR 61 (not 61.7 June 7 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Asmi, Beiersdorf and SSE, on Friday.
A
B
B
B
C
D
D
E
E
I
J
K
L
L
P
R
S
V
V
V
W
P
S

Motor racing-F1 teams harnessing AI for speed and strategy

Motor racing-F1 teams harnessing AI for speed and strategy By Alan Baldwin June 6 (Reuters) - Formula One has a generative AI-designed trophy at the Canadian Grand Prix but, novelty and sponsorship aside, the importance of artificial intelligence for speed and strategy is growing stronger all the time. The various software systems are helping cars go faster and teams become more competitive, crunching terabytes of data to analyse simulations and cut the time it takes to get parts to the racetrac
A
B

Health Rounds: Untreated atrial fibrillation can raise risk of dementia, death

Health Rounds: Untreated atrial fibrillation can raise risk of dementia, death Health Rounds is published on Tuesdays and Thursdays. Think your friend or colleague should know about us? Forward this newsletter to them. They can also subscribe here . By Nancy Lapid June 6(Reuters) - Hello Health Rounds Readers! Today we share some important findings for people with the common heart rhythm disorder atrial fibrillation: taking blood thinners that reduce the risk of strokes may also stave off a form
B
P

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.